BE-Antwerpen-ZNASTUIVENBERG

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Stichting Hemato-Oncologie voor Volwassenen Nederland2 trials

Running trials

• Active, not recruiting

  Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF)

  NCT03645824· Phase 2· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

Closed trials

• Completed

  Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

  NCT01208766· Phase 3· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source